Weight Loss

Medicare’s relationship with GLP-1 drugs is the single most important coverage question in US healthcare policy.

Meal prep solves the biggest practical problem on semaglutide and tirzepatide: protein consistency.

The GLORY-1 phase 3 trial provides the most reliable data on what to expect from mazdutide.

Loose skin is a near-universal consequence of significant weight loss. Bariatric surgery patients have dealt with it for decades.

Liraglutide produces an average of about 8% weight loss at 56 weeks in clinical trials. That figure comes from SCALE (Pi-Sunyer et al.

Introduction A full year on a GLP-1 is enough time to know whether the medication is working, what it is costing you in side…

Yes, GLP-1s can be used postpartum once you’ve stopped breastfeeding and have clearance from your OB or primary care provider.

About 2.1 million weddings happen each year in the United States.

Qsymia was approved in 2012 as the first new prescription weight loss combination drug in years.